MedTrace Logo

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

NCT03066297 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1018

Last updated 2023-12-06

No results posted yet for this study

Summary

The investigatros hypothesized that selection of surgical procedure according to the pre-defined institutional decision-making algorithm will not compromise the treatment outcomes including overall survival and disease-free survival in participants with clinical stage IA non-small cell lung cancer.

The purpose of this study is to determine the outcome of participants with clinical stage IA NSCLC treated by 3 types of surgical resection (wide wedge resection, segmentectomy, or lobectomy) according to the institutional decision-making algorithm

The investigators are planning to enroll 1,000 participants who meet the pre-defined eligibility criteria over 5 years.

Conditions

  • Stage IA Non-small Cell Lung Cancer

Interventions

PROCEDURE

Extent of pulmonary resection

Extent of pulmonary resection selected based on the institutional decision-making algorithm

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hong Kwan Kim, MD, PhD · Samsung Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2027-02-15
Completion
2027-02-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03066297 on ClinicalTrials.gov